Factors relating to poor survival rates of aged cervical cancer patients: A population-based study with the relative survival model in Osaka, Japan

Asian Pacific Journal of Cancer Prevention

Volumn 10, Issue 3, 2009, Pages 457-462

  Ioka, Akiko ^a   Ito, Yuri ^a   Tsukuma, Hideaki ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

Age; Cancer stage; Cervical cancer; Relative excess risk

Indexed keywords

EID: 77951158374     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Agurto I, Sandoval J, De La Rosa M, Guardado ME (2006). Improving cervical cancer prevention in a developing country. Int J Qual Health Care, 18, 81-6.
2. Ajiki W, Tsukuma H, Oshima A (2004). Trends in cancer incidence and survival in Osaka. In 'Cancer Mortality and Morbidity Statistics: Japan and the World-2004, Gann Monograph on Cancer Research No. 51', Eds Tajima K, Kuroishi T, Oshima A. Japan Sci Soc Press, Tokyo, pp137-63.
3. Benedet JL, Bender H, Jones H3rd, Ngan HY, Pecorelli S (2000). FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet, 70, 209-62.
4. Curado MP, Edwards B, Shin HR, et al (eds) (2007). Cancer Incidence in Five Continents Vol. 9. In 'IARC scientific publ No.160'. International Agency for Research on Cancer, Lyon.
5. de Perrot M, Licker M, Reymond MA, Robert J, Spiliopoulos A (1999). Influence of age on operative mortality and long-term survival after lung resection for bronchogenic carcinoma. Eur Respir J, 14, 419-22.
6. Dickman PW, Sloggett A, Hills M, Hakulinen T (2004). Regression models for relative survival. Stat Med, 23, 51-64.
7. Dietrich AJ, Tobin JN, Cassells A, et al (2007). Translation of an efficacious cancer-screening intervention to women enrolled in a Medicaid managed care organization. Ann Fam Med, 5, 320-27.
8. Green JA, Kirwan JM, Tierney JF, et al (2001). Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet, 358, 781-6.
9. Ioka A, Tsukuma H, Ajiki W, Oshima A (2005). Influence of age on cervical cancer survival in Japan. Jpn J Clin Oncol, 35, 464-469.
10. Kinoshita N, Ajiki W, Koyama Y, et al (1998). Trends in relative 5-year survival rates of uterus cancer patients-Introduction of age standardization. Jpn J Cancer Clin, 44, 1101-6 (in Japanese).
11. Leyden WA, Manos MM, Geiger AM, et al (2005). Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. J Natl Cancer Inst, 97, 675-83.
12. Macgregor JE, Campbell MK, Mann EM, Swanson KY (1994). Screening for cervical intraepithelial neoplasia in north east Scotland shows fall in incidence and mortality from invasive cancer with concomitant rise in preinvasive disease. BMJ, 308, 1407-11.
13. Mandelblatt JS, Hadley J, Kerner JF, et al (2000). Patterns of breast carcinoma treatment in older women: patient preference and clinical and physical influences. Cancer, 89, 561-73.
14. Marcus AC, Crane LA (1998). A review of cervical cancer screening intervention research: implications for public health programs and future research. Prev Med, 27, 13-31.
15. Neoadjuvant Chemotherapy for Cervical Cancer Meta-Analysis Collaboration (NACCCMA) Collaboration (2004). Neoadjuvant chemotherapy for locally advanced cervix cancer. Cochrane Database Syst Rev, 2, CD001774.
16. Neugut AI, Fleischauer AT, Sundararajan V, et al (2002). Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study. J Clin Oncol, 20, 2643-50.
17. Osaka Prefectural Department of Environment and Public Health, Osaka Medical Association, Osaka Medical Center for Cancer and Cardiovascular Diseases (1998). Survival of cancer patients in Osaka 1975-89. Osaka Foundation for Prevention of Cancer and Circulatory Disease, Osaka.
18. Quinn M, Babb P, Jones J, Allen E (1999). Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. BMJ, 318, 904-8.
19. StataCorp (2006). Stata Statistical Software: Release 9.0. Stata Corporation, Texas.
20. Sung HY, Kearney KA, Miller M, et al (2000). Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan. Cancer, 88, 2283-9.
21. Wagner TH, Engelstad LP, McPhee SJ, Pasick RJ (2007). The costs of an outreach intervention for low-income women with abnormal Pap smears. Prev Chronic Dis, 4, A11.
22. Wright JD, Gibb RK, Geevarghese S, et al (2005). Cervical carcinoma in the elderly: an analysis of patterns of care and outcome. Cancer, 103, 85-91.